Endothelial dysfunction in hypertension is independent from the etiology and from vascular structure.

The aim of our study was to evaluate the relationships between endothelial function, small resistance artery structure, and blood pressure in patients with primary or secondary hypertension. Sixty subjects were included in the study: 9 patients with pheochromocytoma, 10 with primary aldosteronism, 17 with renovascular hypertension, and 13 with essential hypertension with 11 normotensive subjects who served as controls. Clinic and 24-hour ambulatory blood pressure (ABPM) were evaluated. All subjects were submitted to a biopsy of subcutaneous fat. Small resistance arteries were dissected and mounted on a micromyograph and the media/lumen ratio was calculated. A dose-response curve to acetylcholine was performed at cumulative concentrations from 10(-9) to 10(-5) mol/L. The vasodilator response to acetylcholine was similarly impaired in the four groups of hypertensive patients (ANOVA P<.05 versus normotensive controls), without any significant difference among them. In subcutaneous small arteries of patients with either primary aldosteronism or renovascular hypertension, a marked increase in media:lumen ratio was observed, while in patients with pheochromocytoma, the extent of vascular structural alterations was similar to that observed in essential hypertension. No significant correlation between media-lumen ratio or clinic blood pressure and maximum acetylcholine-induced vasodilatation was observed. On the contrary, a significant, albeit not very close, correlation between ABPM values and maximum acetylcholine-induced vasodilatation was observed (r=34, P<.05 with 24-hour systolic blood pressure, r=0.36, P<.05 with 24-hour diastolic blood pressure). In conclusion, endothelial dysfunction seems to be independent from the degree of vascular structural alterations and from the etiology of hypertension, and it is probably more linked to the hemodynamic load.

[1]  R. Zulli,et al.  Prolonged effects of short-term fosinopril on blood pressure and vascular morphology and function in rats. , 1997, American journal of hypertension.

[2]  M. Copland,et al.  Basal nitric oxide synthesis in essential hypertension , 1997, The Lancet.

[3]  Giuseppe Mancia,et al.  Ambulatory Blood Pressure Is Superior to Clinic Blood Pressure in Predicting Treatment-Induced Regression of Left Ventricular Hypertrophy , 1997 .

[4]  E. Porteri,et al.  Vascular hypertrophy and remodeling in secondary hypertension. , 1996, Hypertension.

[5]  E. Schiffrin,et al.  Structure and function of resistance arteries of hypertensive patients treated with a p-blocker or a calcium channel antagonist , 1996, Journal of hypertension.

[6]  L. Ghiadoni,et al.  Defective L-arginine-nitric oxide pathway in offspring of essential hypertensive patients. , 1996, Circulation.

[7]  E. Porteri,et al.  Effects of low and high doses of fosinopril on the structure and function of resistance arteries. , 1995, Hypertension.

[8]  E. Schiffrin,et al.  Comparison of effects of angiotensin I-converting enzyme inhibition and beta-blockade for 2 years on function of small arteries from hypertensive patients. , 1995, Hypertension.

[9]  E. Porteri,et al.  Delayed development of hypertension after short-term nitrendipine treatment. , 1994, Hypertension.

[10]  E. Porteri,et al.  Vascular structural and functional alterations before and after the development of hypertension in SHR. , 1994, American journal of hypertension.

[11]  A. Salvetti,et al.  Vasodilation to acetylcholine in primary and secondary forms of human hypertension. , 1993, Hypertension.

[12]  R. Zulli,et al.  Relationship between initial cardiovascular structural changes and daytime and nighttime blood pressure monitoring. , 1992, American journal of hypertension.

[13]  M. Clozel,et al.  Effects of angiotensin converting enzyme inhibitors and of hydralazine on endothelial function in hypertensive rats. , 1990, Hypertension.

[14]  M. Mulvany,et al.  Structure and function of small arteries. , 1990, Physiological reviews.

[15]  Paul M. Vanhoutte,et al.  The Endothelium: Modulator of Cardiovascular Function , 1990 .

[16]  M. Mulvany,et al.  Abnormal structure and function of isolated subcutaneous resistance vessels from essential hypertensive patients despite antihypertensive treatment. , 1989, Journal of hypertension.

[17]  D. Rizzoni,et al.  Assessment of semi-automated catecholamine assay by HPLC: Choice of reverse phase C18 or cation-exchange columns , 1987 .

[18]  A. Heagerty,et al.  Evidence for increased media thickness, increased neuronal amine uptake, and depressed excitation--contraction coupling in isolated resistance vessels from essential hypertensives. , 1987, Circulation research.

[19]  G Parati,et al.  Relationship of 24-hour blood pressure mean and variability to severity of target-organ damage in hypertension. , 1987, Journal of hypertension.

[20]  B. Folkow Physiological aspects of primary hypertension. , 1982, Physiological reviews.

[21]  M. Mulvany,et al.  Direct Evidence that the Greater Contractility of Resistance Vessels in Spontaneously Hypertensive Rats is Associated with a Narrowed Lumen, a Thickened Media, and an Increased Number of Smooth Muscle Cell Layers , 1978, Circulation research.

[22]  M. Mulvany,et al.  Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. , 1977, Circulation research.